Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

cannabis-producer-moves-to-the-tsx-as-analyst-flags-major-expansion-potential

Cannabis Producer Moves to the TSX as Analyst Flags Major Expansion Potential

Mar 10, 2026

Cannara Biotech Inc. (LOVE:TSX; LOVFF:OTCQX; BCB0:FSE) began trading on the Toronto Stock Exchange at the open on March…

Read more
will-new-analyst-coverage-and-conference-spotlight-change-inventrust-properties’-(ivt)-sun-belt-grocery-narrative?

Will New Analyst Coverage And Conference Spotlight Change InvenTrust Properties’ (IVT) Sun Belt Grocery Narrative?

Mar 10, 2026

InvenTrust Properties Corp. recently presented at Citi’s Miami Global Property CEO Conference 2026, while KeyBanc Capital Markets began…

Read more
wrb:-evercore-isi-maintains-underperform-on-w-r.-berkley-march-9,-2026

WRB: Evercore ISI Maintains Underperform on W. R. Berkley March 9, 2026

Mar 10, 2026

Evercore ISI maintained an Underperform rating on W. R. Berkley Corporation (WRB) on March 9, 2026. This WRB…

Read more
bofa-maintains-buy-on-sea-limited-(se)-march-09,-2026-with-pt-cut-to-$125

BofA Maintains Buy on Sea Limited (SE) March 09, 2026 with PT cut to $125

Mar 10, 2026

Bank of America Securities maintained a Buy rating on Sea Limited (SE) on March 09, 2026, while lowering…

Read more
maintained-buy:-rapp-analyst-rating-on-rapport-therapeutics,-inc.-common-stock-mar-2026

Maintained Buy: RAPP analyst rating on Rapport Therapeutics, Inc. Common Stock Mar 2026

Mar 10, 2026

BTIG and Cowen each maintained a Buy rating on Rapport Therapeutics, Inc. Common Stock (RAPP) on March 9,…

Read more
guggenheim-maintains-buy-on-live-nation-(lyv)-march-9,-2026

Guggenheim Maintains Buy on Live Nation (LYV) March 9, 2026

Mar 10, 2026

The latest LYV analyst rating came on March 9, 2026, when Guggenheim maintained its Buy on Live Nation…

Read more
raymond-james-maintains-strong-buy-on-klrs-kalaris-therapeutics-inc-mar-2026

Raymond James Maintains Strong Buy on KLRS Kalaris Therapeutics Inc Mar 2026

Mar 10, 2026

Raymond James maintained a Strong Buy on Kalaris Therapeutics Inc (KLRS) on March 09, 2026. The note was…

Read more
needham-upgrades-hims-&-hers-(hims)-to-buy-on-march-9,-2026

Needham upgrades Hims & Hers (HIMS) to Buy on March 9, 2026

Mar 10, 2026

On March 9, 2026 Needham upgraded Hims & Hers Health, Inc. (HIMS) to Buy. The move shifted the…

Read more
bofa-securities-maintains-buy-on-slm-corporation-(slmbp)-march-9-2026

BofA Securities Maintains Buy on SLM Corporation (SLMBP) March 9 2026

Mar 10, 2026

BofA Securities maintained a Buy on SLM Corporation (SLMBP) on March 09, 2026. The SLMBP analyst rating note…

Read more
assessing-itron-(itri)-valuation-after-new-analyst-coverage-and-utilityiq-module-expansion

Assessing Itron (ITRI) Valuation After New Analyst Coverage And UtilityIQ Module Expansion

Mar 10, 2026

Itron (ITRI) has drawn fresh attention after expanding its UtilityIQ Application Suite to support new Cellular 500G and…

Read more
oppenheimer,-cowen,-hc.-wainwright-maintain-buy/outperform-on-olma-march-2026

Oppenheimer, Cowen, H.C. Wainwright Maintain Buy/Outperform on OLMA March 2026

Mar 10, 2026

OLMA analyst rating updates on March 9, 2026 show three firms kept positive calls on Olema Pharmaceuticals, Inc.…

Read more
william-blair-maintains-outperform-for-caterpillar-inc.-(cat)-march-9,-2026

William Blair Maintains Outperform for Caterpillar Inc. (CAT) March 9, 2026

Mar 10, 2026

The latest CAT analyst rating shows William Blair maintained an Outperform on Caterpillar Inc. (CAT) on March 9,…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 28
  6. 29
  7. 30
  8. 31
  9. 32
  10. 33
  11. 34
  12. ...
  13. 394
  14. »

Posts pagination

Newer posts Page 1 … Page 31 … Page 394 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.